Ticker

Analyst Price Targets — XRAY

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
October 26, 2026 11:36 am—Barrington$13.00$9.43TheFly Dentsply Sirona price target lowered to $13 from $15 at Barrington
October 22, 2026 11:12 am—Mizuho Securities$12.00$9.08TheFly Dentsply Sirona price target lowered to $12 from $14 at Mizuho
October 14, 2026 12:50 pm—Leerink Partners$10.00$8.43TheFly Dentsply Sirona price target lowered to $10 from $14 at Leerink
October 9, 2026 11:28 am—Piper Sandler$12.00$8.69TheFly Dentsply Sirona price target lowered to $12 from $14 at Piper Sandler
September 17, 2026 11:46 amVik ChopraBMO Capital$10.00$10.14TheFly Dentsply Sirona price target lowered to $10 from $13 at BMO Capital
August 24, 2026 9:54 am—Barclays$11.00$10.92TheFly Dentsply Sirona price target raised to $11 from $9 at Barclays
August 10, 2026 1:17 pm—Barrington$15.00$11.87TheFly Dentsply Sirona price target lowered to $15 from $17 at Barrington
August 7, 2026 11:59 am—BMO Capital$13.00$12.04TheFly Dentsply Sirona price target raised to $13 from $12 at BMO Capital
July 29, 2026 11:45 am—Piper Sandler$14.00$13.49TheFly Dentsply Sirona price target raised to $14 from $13 at Piper Sandler
July 8, 2026 8:23 pm—BMO Capital$12.00$11.78TheFly Dentsply Sirona initiated with a Market Perform at BMO Capital

Latest News for XRAY

Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5

CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, November 5, 2026, at 4:30 p.m. EST to review its third quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at…

GlobeNewsWire • Oct 20, 2026
Dentsply Sirona (NASDAQ: XRAY) secures covenant relief in debt amendments

What happened Dentsply Sirona Inc. (NASDAQ: XRAY) said on October 8, 2026, that lenders consented to amendments to its revolving credit facility and related note agreements. The company entered the Third Amendment to Credit Agreement, dated September 30, 2026, and three Note Purchase Agreement Amendments for the 2015, 2016 and 2019 notes. The amendments raise

Defense World • Oct 12, 2026
Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

MÖLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Wellspect HealthCare today announced that the Surity™ portfolio, including the Surity™ Urinary Management System and Surity™ Female and Male External Catheters, may be covered by traditional Medicare for eligible beneficiaries when medically necessary. This milestone represents an important step in expanding access and reducing barriers to at-home management for…

GlobeNewsWire • Oct 7, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

Senate Trading Disclosures

NameTransaction DateTypeAssetAmountLink

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top